|
(PQ4) Anal HPV infection and anal HSIL among HIV-infected MSM aged 50+ years
|
5R01CA206477-03
|
$791,933
|
PALEFSKY, JOEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQ5) Informing anal neoplasia differences/similarities in HIV-serodiscordant individuals
|
3R21CA216830-02S1
|
$68,478
|
SHIRAMIZU, BRUCE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
(PQ5) Informing anal neoplasia differences/similarities in HIV-serodiscordant individuals
|
5R21CA216830-02
|
$192,500
|
SHIRAMIZU, BRUCE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
AHCC for the Treatment of HPV Infections to Prevent Cancer
|
5R03CA212935-02
|
$77,000
|
SMITH, JUDITH
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
|
Annual anal sampling using DNA screening to identify men who have sex with men at increased risk for anal cancer
|
7R01CA215403-02
|
$551,568
|
NYITRAY, ALAN
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Biomarkers of human papillomavirus (HPV) infection and risk of two increasing cancers
|
5U01CA195603-04
|
$443,239
|
BRENNAN, PAUL
|
INTERNATIONAL AGENCY FOR RES ON CANCER
|
|
Cancer Center Support Grant
|
3P30CA015704-43S1
|
$78,024
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-43S2
|
$199,999
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-43S3
|
$246,630
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-43S4
|
$225,000
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-43S5
|
$33,324
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
5P30CA015704-43
|
$9,559,285
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S1
|
$84,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S2
|
$206,488
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S3
|
$257,838
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-09S1
|
$249,371
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-09
|
$2,480,000
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
CCR Vaccine Branch FACS Core
|
ZIC BC 010936
|
$351,148
|
McKinnon, Katherine
|
CCR (NCI)
|
|
Cell Production Core Facility
|
ZIC BC 011569
|
$897,301
|
Somerville, Robert
|
CCR (NCI)
|
|
Clinical Interventional Studies of HIV Reservoirs
|
ZIA BC 011464
|
$569,671
|
Maldarelli, Frank
|
CCR (NCI)
|
|
Defining Drivers of HPV-associated Carcinogenesis
|
5R35CA210807-02
|
$918,000
|
LAMBERT, PAUL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Determining the accuracy of self- and partner anal exams for detecting anal abnormalities.
|
1R01CA232892-01
|
$671,057
|
NYITRAY, ALAN
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Development of Novel Therapies for HIV Infection
|
ZIA SC 006737
|
$49,491
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Evaluating Companion Diagnostics to the anal Pap test to improve prediction of AIN2+ in HIV-infected MSM
|
5R01CA203604-02
|
$362,695
|
JORDAN, JEANNE
|
GEORGE WASHINGTON UNIVERSITY
|
|
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
|
5U54CA190163-05
|
$701,988
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Infection and Cancer Research: A New Frontier in Cancer Prevention and Control
|
5K05CA181320-05
|
$86,194
|
GIULIANO, ANNA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Medical Oncology HIV-AIDS Clinical Research
|
ZID BC 011683
|
$226,739
|
Gulley, James
|
CCR (NCI)
|
|
Papillomavirus Virion Proteins and Vaccines
|
ZIA BC 010579
|
$1,455,794
|
Lowy, Douglas
|
CCR (NCI)
|
|
Papillomavirus Virion Proteins and Vaccines
|
ZIA BC 009052
|
$552,447
|
Schiller, John
|
CCR (NCI)
|
|
Prompt Gamma Imaging for the in-vivo range verification during proton radiotherapy
|
5R01CA187416-04
|
$533,099
|
POLF, JERIMY
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Small DNA Tumor Viruses and Human Cancer
|
5R50CA211246-03
|
$128,701
|
SPURGEON, MEGAN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Stable Water Isotope Labeling for Imaging of Rapidly Proliferating Cells
|
ZIA BC 011777
|
$32,855
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
STING Activating Synthetic Nanovaccine for HPV-Induced Cancers
|
1R01CA216839-01A1
|
$376,428
|
GAO, JINMING
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Surgical Consultative Services in the Thoracic and Oncologic Surgery Branch
|
ZID BC 011541
|
$2,146,324
|
Schrump, David
|
CCR (NCI)
|
|
T-cell receptor gene therapy for cancer
|
ZIA BC 011479
|
$1,424,997
|
Hinrichs, Christian
|
CCR (NCI)
|
|
The Microbiome and Anal Cancer Pathogenesis in HIV-infected Men who have Sex with Men
|
5R03CA203589-02
|
$79,250
|
PALEFSKY, JOEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial
|
3R01CA213130-02S1
|
$88,149
|
MADELEINE, MARGARET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial
|
5R01CA213130-02
|
$753,320
|
MADELEINE, MARGARET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
TOSB Surgical Oncology Fellowship Program
|
ZIE BC 011542
|
$1,126,820
|
Schrump, David
|
CCR (NCI)
|
|
Treating high grade intraepithelial lesions of the anus with photodynamic therapy
|
1R21CA223366-01A1
|
$210,105
|
BUSCH, THERESA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Tumor-Infiltrating Lymphocytes in Anal Cancer and Pre-malignant Anal Lesions
|
1K07CA225404-01A1
|
$148,457
|
SUDENGA, STACI
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies
|
5U54CA221208-02
|
$670,069
|
MESRI, ENRIQUE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
University of Hawaii Cancer Center CCSG
|
2P30CA071789-18
|
$1,913,800
|
HOLCOMBE, RANDALL
|
UNIVERSITY OF HAWAII AT MANOA
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S1
|
$629,550
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S2
|
$200,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S3
|
$125,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
5P30CA134274-11
|
$2,266,216
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|